Standout Papers
- Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy (2002)
- Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat (1999)
- IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial (2021)
Immediate Impact
11 from Science/Nature 60 standout
Citing Papers
Clonal Hematopoiesis of Indeterminate Potential With Loss of Tet2 Enhances Risk for Atrial Fibrillation Through Nlrp3 Inflammasome Activation
2024 Standout
Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials
2023 Standout
Works of Michael Davidson being referenced
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
2021 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Michael Davidson | 1378 | 1236 | 279 | 2396 | 117 | 6.8k | |
| Maria Ida Maiorino | 1105 | 1057 | 3 | 3843 | 175 | 6.7k | |
| Bu B. Yeap | 856 | 527 | 20 | 3870 | 293 | 8.5k | |
| Grant D. Huang | 509 | 857 | 14 | 2823 | 94 | 7.4k | |
| Christopher Patterson | 808 | 914 | 12 | 1193 | 156 | 7.2k | |
| Jordan D. Tobin | 561 | 1416 | 4 | 3206 | 59 | 8.2k | |
| Marja‐Liisa Dahl | 2104 | 473 | 31 | 807 | 148 | 8.4k | |
| Claudine Legault | 589 | 815 | 5 | 1914 | 75 | 5.1k | |
| Richard R. Rubin | 452 | 1037 | 25 | 6631 | 94 | 10.7k | |
| Rachel A. Whitmer | 2818 | 648 | 10 | 1623 | 217 | 8.8k | |
| Andrew P. Goldberg | 857 | 1549 | 7 | 1927 | 156 | 9.3k |
All Works
Login with ORCID to disown or claim papers
Loading papers...